GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (NSE:BIOFILCHEM) » Definitions » Interest Expense

Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Interest Expense : ₹-0.4 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biofil Chemicals & Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biofil Chemicals & Pharmaceuticals's interest expense for the three months ended in Mar. 2024 was ₹ -0.2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-0.4 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biofil Chemicals & Pharmaceuticals's Operating Income for the three months ended in Mar. 2024 was ₹ -1.1 Mil. Biofil Chemicals & Pharmaceuticals's Interest Expense for the three months ended in Mar. 2024 was ₹ -0.2 Mil. Biofil Chemicals & Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biofil Chemicals & Pharmaceuticals Interest Expense Historical Data

The historical data trend for Biofil Chemicals & Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofil Chemicals & Pharmaceuticals Interest Expense Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.21 -0.64 -0.41 -0.43 -0.42

Biofil Chemicals & Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.11 -0.10 - -0.21

Biofil Chemicals & Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals  (NSE:BIOFILCHEM) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biofil Chemicals & Pharmaceuticals's Interest Expense for the three months ended in Mar. 2024 was ₹-0.2 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹-1.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹0.0 Mil.

Biofil Chemicals & Pharmaceuticals's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Biofil Chemicals & Pharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (NSE:BIOFILCHEM) » Definitions » Interest Expense
Comparable Companies
BOM:524202 BOM:542934 BOM:524652 BOM:530233 BOM:524711 BOM:524636 BOM:506919 BOM:530317 BOM:539938 BOM:542248 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
524396:India
Address
11/12, Sector E, Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Website
https://www.biofilgroup.net
Biofil Chemicals & Pharmaceuticals Ltd is an Indian-based pharmaceutical company. The company's operating segment includes Pharma and Chemicals. It generates maximum revenue from the Pharma segment.

Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Headlines

No Headlines